Goldman Sachs’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$42.1M Sell
1,273,983
-88,975
-7% -$2.94M 0.01% 1242
2025
Q1
$54.8M Buy
1,362,958
+157,527
+13% +$6.33M 0.01% 1007
2024
Q4
$56.7M Buy
1,205,431
+20,642
+2% +$971K 0.01% 993
2024
Q3
$62.6M Buy
1,184,789
+46,635
+4% +$2.46M 0.01% 919
2024
Q2
$61.7M Buy
1,138,154
+446,705
+65% +$24.2M 0.01% 885
2024
Q1
$48.5M Sell
691,449
-123,995
-15% -$8.69M 0.01% 1006
2023
Q4
$68.1M Buy
815,444
+105,994
+15% +$8.85M 0.01% 823
2023
Q3
$20.9M Sell
709,450
-396,788
-36% -$11.7M ﹤0.01% 1469
2023
Q2
$36.1M Buy
1,106,238
+31,714
+3% +$1.03M 0.01% 1140
2023
Q1
$37.8M Buy
1,074,524
+164,273
+18% +$5.78M 0.01% 1081
2022
Q4
$41.7M Buy
910,251
+232,167
+34% +$10.6M 0.01% 1092
2022
Q3
$32.9M Buy
678,084
+207,331
+44% +$10M 0.01% 1229
2022
Q2
$18.5M Sell
470,753
-190,693
-29% -$7.49M ﹤0.01% 1669
2022
Q1
$24.3M Buy
661,446
+102,742
+18% +$3.78M 0.01% 1590
2021
Q4
$25.5M Sell
558,704
-425,761
-43% -$19.4M 0.01% 1596
2021
Q3
$35.2M Buy
984,465
+421,962
+75% +$15.1M 0.01% 1324
2021
Q2
$11.1M Sell
562,503
-242,785
-30% -$4.8M ﹤0.01% 2174
2021
Q1
$18.7M Sell
805,288
-18,476
-2% -$430K ﹤0.01% 1726
2020
Q4
$17.1M Sell
823,764
-75,067
-8% -$1.56M ﹤0.01% 1676
2020
Q3
$19.5M Buy
898,831
+84,192
+10% +$1.82M 0.01% 1493
2020
Q2
$19.2M Buy
814,639
+332,290
+69% +$7.83M 0.01% 1503
2020
Q1
$5.69M Buy
482,349
+155,047
+47% +$1.83M ﹤0.01% 2160
2019
Q4
$3.47M Buy
327,302
+189,598
+138% +$2.01M ﹤0.01% 2636
2019
Q3
$1.57M Buy
137,704
+35,032
+34% +$399K ﹤0.01% 2970
2019
Q2
$1.16M Sell
102,672
-134,157
-57% -$1.51M ﹤0.01% 3105
2019
Q1
$1.92M Buy
236,829
+67,642
+40% +$547K ﹤0.01% 2965
2018
Q4
$1.07M Buy
169,187
+11,028
+7% +$69.7K ﹤0.01% 3090
2018
Q3
$1.56M Sell
158,159
-140,492
-47% -$1.38M ﹤0.01% 2986
2018
Q2
$2.48M Sell
298,651
-55,612
-16% -$462K ﹤0.01% 2797
2018
Q1
$2.55M Sell
354,263
-63,334
-15% -$456K ﹤0.01% 2734
2017
Q4
$3.4M Buy
417,597
+73,031
+21% +$595K ﹤0.01% 2529
2017
Q3
$5M Buy
344,566
+58,548
+20% +$849K ﹤0.01% 2351
2017
Q2
$3.46M Buy
286,018
+234,588
+456% +$2.84M ﹤0.01% 2477
2017
Q1
$661K Sell
51,430
-20,061
-28% -$258K ﹤0.01% 3352
2016
Q4
$869K Sell
71,491
-61,871
-46% -$752K ﹤0.01% 3162
2016
Q3
$1.22M Buy
133,362
+30,523
+30% +$280K ﹤0.01% 2955
2016
Q2
$976K Buy
+102,839
New +$976K ﹤0.01% 2946
2016
Q1
Sell
-35,554
Closed -$372K 4506
2015
Q4
$372K Buy
35,554
+19,420
+120% +$203K ﹤0.01% 3399
2015
Q3
$108K Buy
16,134
+9,099
+129% +$60.9K ﹤0.01% 4136
2015
Q2
$47K Buy
7,035
+2,695
+62% +$18K ﹤0.01% 4437
2015
Q1
$29K Sell
4,340
-74,312
-94% -$497K ﹤0.01% 4372
2014
Q4
$630K Buy
78,652
+1,182
+2% +$9.47K ﹤0.01% 3228
2014
Q3
$273K Buy
77,470
+62,473
+417% +$220K ﹤0.01% 3722
2014
Q2
$72K Sell
14,997
-30,830
-67% -$148K ﹤0.01% 4244
2014
Q1
$435K Buy
+45,827
New +$435K ﹤0.01% 3452
2013
Q4
Sell
-10,583
Closed -$80K 4275
2013
Q3
$80K Buy
+10,583
New +$80K ﹤0.01% 4050